Dasatinib
- Strength
- 80 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals, Inc.
Listed by BluePoint Laboratories
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 68001-662 |
| FDA application | ANDA217217 |
| RxNorm concept | 643105 |
| Package sizes listed | 1 |
| Marketed since | November 2025 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Teva Pharmaceuticals, Inc.
Dr.Reddys Laboratories Inc
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited
Aurobindo Pharma Limited
Apotex Corp.
Apotex Corp.
Prasco Laboratories
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.